Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
From a Surgeon's Perspective: How to Choose the Best Rhinoplasty Surgeon for You
-
CrowdStrike and CoreWeave Partner to Power the Secure AI Cloud for the Agentic Era
-
The $300 Organic Cotton Illusion -- Introducing Bedsure's GentleSoft® Organic Cotton Sheet Set
-
Cybersecurity Leader Armis Closes $435 Million Round at $6.1 Billion Valuation
-
Unity Reports Third Quarter 2025 Financial Results
-
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.34 per Common Share
-
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
-
Youth Champions Springboard Summit 2025: Empowering 250 LA Students to Think Bigger and Lead with Confidence
-
Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network
-
Kiwi Lands $100 Million Credit Facility to Serve U.S. Hispanic Consumers
-
Albireo Energy Strengthens Presence in Arizona with Local Leadership and Proven Expertise
-
OPENLANE, Inc. Reports Third Quarter 2025 Financial Results
-
Interplay Learning Launches Engagement Services and Expands Apprenticeship Offerings
-
McDONALD'S REPORTS THIRD QUARTER 2025 RESULTS
-
Team Velocity Recognized as a 2025 Inc. Power Partner Award Winner
-
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
-
HTVRONT A300 Auto Hat Heat Press Brings True Automation to Hat Making
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Ansys, Inc. Investors Who Received Synopsys, Inc. (NASDAQ: SNPS) Shares in Connection with Synopsys’s Acquisition of Ansys in July 2025
-
The 4K OLED Xencelabs Pen Display 16 Lite, Now Available
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Mr. Cooper Group Inc. (NASDAQ: COOP) Investors Who Received Rocket Companies, Inc. (NYSE: RKT) Shares in Connection with Rocket’s Acqui
-
Royalty Pharma Reports Third Quarter 2025 Results
-
ACM Research Reports Third Quarter 2025 Results
-
Tandym Group Launches ANDY – an AI Career Mentor Built into Tandym Catalyst™
-
Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
-
Stella-Jones Announces Third Quarter Results
-
ScottsMiracle-Gro Reports Strong Fiscal 2025 Full-Year Results Driven by Robust Gross Margin Expansion and EPS Growth
-
Plug Power Begins 5 MW Electrolyzer Installation for H2 Hollandia, Set to Become the Largest Green Hydrogen Initiative in the Netherlands
-
Alpha Modus Files Patent-Infringement Lawsuit Against Adroit Worldwide Media (AWM) Over Cashierless and Smart-Shelf Technologies
-
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
-
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy
-
MVP Ventures Closes $125 Million Fund II, Reporting Top 5% TVPI Performance and Expanding Its Founder-First Model
-
ADESA Launches CarValue™ Retail and Other Enhancements to Digital Auction Tools
-
OTC Markets Group Welcomes Moon Inc. to OTCQX
-
Prospect Capital Schedules First Fiscal Quarter Earnings Release and Conference Call
-
Aeluma Wins 2025 LEAP Award for Advanced Materials Innovation
-
X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Brink's Delivers Strong Third-Quarter Results
-
Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
-
Enbridge Inc. Declares Quarterly Dividends
-
Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Inspired Reports Third Quarter 2025 Results
-
Macrobond Selected by T. Rowe Price to Support Evolving Research and Investment Workflows
-
Sportradar Reports Third Quarter Financial Results, Raises Full Year 2025 Outlook and Announces Increase in Share Repurchase Program to $300 Million
-
Blue Gold Limited Secures $140m1 to Restart the 5.1m oz Bogoso & Prestea Mold mine, with new institutional investor committing $65m
-
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
-
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
-
Biomea Fusion Showcases Preclinical Advances for BMF-650 and Icovamenib with Low Dose Semaglutide at ObesityWeek® 2025
-
TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
-
Sionna Therapeutics Reports Third Quarter 2025 Financial Results

